drugset / Trial / NCT00672867

A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B

NCT00672867

Phase 3 Completed 102 enrolled Bukwang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and antiviral activity of Clevudine Versus Adefovir dipivoxil in patients with LC-B.

Timeline

Start
2007-12
Primary completion
2012-11
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adefovir dipivoxil Small molecule 10 mg
Subject Clevudine Small molecule 30 mg

Indications

No indication recorded.